Jacobs D G, Piotrowski J J, Hoppensteadt D A, Salvator A E, Fareed J
Carolinas Medical Center, Charlotte, North Carolina 28232-2861, USA.
J Trauma. 1996 May;40(5):710-16; discussion 716-7. doi: 10.1097/00005373-199605000-00005.
To elucidate the time course and magnitude of hemodynamic and fibrinolytic changes associated with sequential gradient intermittent pneumatic compression (SGIPC).
Two-phase, intervention and response investigation in normal volunteers.
Subjects were assigned to control (phase I) or compression (phase II) groups. Serial blood samples were obtained via femoral venous catheters for tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI-1), tPA-PAI-1 complex (tPA-PAI), and euglobulin lysis time (ELT) from all subjects and for fibrin degradation products (FbDP) and fibrinogen degradation products (FgDP) from phase II subjects. Duplex venous scanning was carried out on phase II subjects before and during SGIPC.
Catheter placement caused elevations in PAI-1 and tPA-PAI, which stabilized within 4 hours of catheter insertion. In phase II, SGIPC induced significant increases in FbDP, FgDP, and tPA-PAI and decreases in ELT and PAI-1, all of which quickly reverted to baseline on termination of compression. Femoral venous blood flow increased by more than 100% with SGIPC.
Sequential gradient intermittent pneumatic compression induces prompt, but short-lived, alterations in both fibrinolytic and hemodynamic function. Noncontinuous SGIPC may result in suboptimal thromboembolic prophylaxis.
阐明与序贯梯度间歇性气动压迫(SGIPC)相关的血流动力学和纤溶变化的时间进程及程度。
对正常志愿者进行的两阶段干预与反应性研究。
将受试者分为对照组(第一阶段)和压迫组(第二阶段)。通过股静脉导管采集所有受试者的系列血样,检测组织型纤溶酶原激活物(tPA)、纤溶酶原激活物抑制剂(PAI - 1)、tPA - PAI - 1复合物(tPA - PAI)和优球蛋白溶解时间(ELT),并采集第二阶段受试者的纤维蛋白降解产物(FbDP)和纤维蛋白原降解产物(FgDP)。对第二阶段受试者在SGIPC之前和期间进行双功静脉扫描。
导管置入导致PAI - 1和tPA - PAI升高,在导管插入后4小时内稳定。在第二阶段,SGIPC导致FbDP、FgDP和tPA - PAI显著增加,ELT和PAI - 1降低,所有这些在压迫终止后迅速恢复至基线水平。SGIPC使股静脉血流增加超过100%。
序贯梯度间歇性气动压迫可引起纤溶和血流动力学功能迅速但短暂的改变。非连续性SGIPC可能导致血栓栓塞预防效果欠佳。